Post by Bausch+Ströbel

🔍 Over the past few weeks, we have shared a range of technical solutions designed to help pharmaceutical manufacturers meet the requirements of EU GMP Annex 1. From intelligent automation and advanced barrier technologies to optimized machine designs, our goal is to enable sterile manufacturing processes that are safe, efficient, and future-ready. 💡 If you missed our previous posts, explore our Annex 1 solutions here: https://lnkd.in/eNmVbrHj However, Annex 1 compliance is not only about investing in new equipment. For many pharmaceutical manufacturers, the priority is to integrate Annex 1-compliant technologies into existing production lines. This means enhancing established systems with advanced solutions for contamination control, quality risk management, and barrier technologies – while building on the strengths of the current equipment. 🤝 This is where our service expertise comes into play. Our specialists support you in systematically assessing your existing equipment in the context of Annex 1 requirements. Together, we identify potential risks, uncover optimization opportunities, and define tailored solutions for integrating compliant technologies into your production environment. From initial assessment and consulting to implementation and qualification support, we provide a clear and structured roadmap towards sustainable compliance, increased process reliability, and long-term operational excellence. 🚀 Because Annex 1 compliance is more than a regulatory requirement – it is a strategic step towards future-proof aseptic manufacturing. At Bausch+Ströbel, we see ourselves as a partner throughout the entire lifecycle of your equipment. Our goal is not only to help you achieve compliance today, but also to ensure that your production remains efficient, reliable, and economically sustainable for years to come.   Because long term success requires more than technology. It requires a partner who understands the complete lifecycle of your operations.